Identification and Validation of Differentiation Therapy for Osteosarcoma
|
Dana-Farber Cancer Institute / Katherine Janeway, MD |
Young Investigator Grants |
2008 |
Massachusetts |
The role of vitamin D in hepatoblastoma formation and prevention |
Brigham and Women's Hospital / Wolfram Goessling, MD/PhD |
Innovation Grants |
2012 |
Massachusetts |
Characterizing Inflammatory Phenotypes Associated with RUNX1 Deficiency |
Dana-Farber Cancer Institute / Waihay Wong, MD/PhD |
RUNX1 Early Career Investigator Grants |
2021 |
Massachusetts |
Olfactory Ensheathing Cells for Pediatric Glioma Gene/Cell Therapy |
Massachusetts General Hospital / Bakhos Tannous, PhD |
Innovation Grants |
2018 |
Massachusetts |
Elucidating Mechanisms Driving Renal Medullary Carcinomas to Deliver a Rational Approach to Cancer
Directed Therapy
|
Dana-Farber Cancer Institute / Andrew Hong, MD |
Young Investigator Grants |
2015 |
Massachusetts |
Epigenetic regulation of genomic instability and its therapeutic implications in T-cell acute lymphoblastic leukemia |
Dana-Farber Cancer Institute / Birgit Knoechel, MD/PhD |
Innovation Grants |
2019 |
Massachusetts |
Exploiting the Differentiation Potential of Pediatric High-Grade Glioma to Discover Novel Therapeutic Opportunities |
Dana-Farber Cancer Institute / Mariella Filbin, MD/PhD |
'A' Award Grants |
2019 |
Massachusetts |
A Translational Approach to Identify Drugs with Specific Activity Against EZH2 Mutant High Risk T-ALLs and ETP ALLs that Overexpress the JDP2 bZIP Transcription Factor |
Dana-Farber Cancer Institute / Shuning He, PhD |
Young Investigator Grants |
2015 |
Massachusetts |
Discovery of New Targets and Pathways for T-ALL Therapy |
Dana-Farber Cancer Institute / Thomas Look |
Bridge Grants |
2012 |
Massachusetts |
Development of RADARS-based Therapy to Treat Fusion Molecule Driven Pediatric Malignancies |
Boston Children’s Hospital / Alan B. Cantor, MD, PhD |
Innovation Grants |
2023 |
Massachusetts |